Drug Profile
Research programme: Proto oncogene proteins c-akt inhibitors - Novelion Therapeutics
Alternative Names: KP372-1; Research programme: PKB inhibitors - KinetekLatest Information Update: 30 Nov 2016
Price :
$50
*
At a glance
- Originator QLT
- Class Small molecules
- Mechanism of Action Proto oncogene protein c-akt inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer